Bitlayer Labs Raises $11M in Series A Funding

Category: Finance

Bitlayer Labs, a Singapore-based Bitcoin Layer 2 company, raised $11M in Series A funding, totaling $16M. Led by Franklin Templeton and ABCDE, the funds will be used for growth and development. Bitlayer aims to enhance Bitcoin's scalability and security through its innovative Layer 2 solution based on the BitVM paradigm.

Keywords: Bitcoin, Layer 2, Funding

Source: FinSMEs

Update At: 7/23/2024

Related Sources

What channel is Columbus Crew v Aston Villa friendly match on? TV coverage, live stream and kick-off time

In 2023, the average amount borrowed by new customers taking out equity release plans was £97,878, according to the Equity Release Council.

Radio Times

7 Stocks That Are Capitalizing on the Digital World

The article highlights the significant time Americans spend on digital devices and the investment potential in digital stocks. Companies like Meta Platforms, Amazon, Alphabet, Fortinet, Upwork, Semrush, and Duolingo are discussed for their growth, revenue, and market opportunities, despite some facing challenges. The digital landscape offers both opportunities and risks for investors.

Yahoo Finance

3 Social Media Stocks to Buy on the Dip: July 2024

Social media stocks are currently undervalued due to a rotation out of technology securities, despite the sector's significant growth and influence. With nearly five billion users globally, social media advertising revenue is projected to rise significantly. Key stocks to consider include Pinterest, Meta Platforms, and Alphabet, all of which have shown potential for recovery and growth in the coming months.

InvestorPlace

3 Social Media Stocks That Will Have Better Returns Than META

Meta Platforms has surged to nearly $500 per share from lows of $90, prompting investors to seek other promising social media stocks. The Growth at a Reasonable Price (GARP) strategy highlights three potential multi-baggers: Alphabet Inc, Spotify, and Tencent. Alphabet leads in search and video with strong financials and AI investments. Spotify dominates music streaming with a growing user base and strategic price hikes. Tencent, despite a stock decline, maintains a significant market share in gaming and social media, showcasing robust revenue growth and a strong game portfolio.

Yahoo Finance

3 Social Media Stocks That Are Attracting More Users and Profits

High user growth rates and solid financials characterize leading social media stocks like Meta Platforms, Alphabet, and Microsoft. Meta has seen a 27% revenue increase and a 117% rise in net income year-over-year, while Alphabet's YouTube generated $8.1 billion in ad revenue, reflecting a 20.9% YOY increase. Microsoft, with its LinkedIn platform, has also shown steady growth, gaining 20% YTD. These companies are well-positioned for future growth and dividend increases.

InvestorPlace

3 Social Media Stocks to Buy Now: Q3 Edition

Over 60% of the global population uses social media, with significant growth expected in developing countries. The article highlights three social media stocks to consider: Spotify, which is focusing on monetization and user growth; Meta, which is investing in the metaverse and has a large user base; and Pinterest, which is enhancing user engagement through AI despite current profitability challenges.

InvestorPlace

Pfizer stock gains after raising annual earnings outlook (NYSE:PFE)

Pfizer's shares rose 4.1% after the company exceeded Q2 earnings expectations and raised its full-year outlook, driven by its oncology portfolio and cost realignment efforts. Adjusted earnings were $0.60 per share on $13.28B revenue, marking the first year-over-year revenue growth since Q4 2022. Despite declines in COVID-19 product revenues, overall operational revenue grew 3%. The company raised its 2024 revenue guidance by $1B, anticipating 9-11% growth excluding COVID products.

Seeking Alpha

Pfizer Earnings Are Imminent; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call - Pfizer (NYSE:PFE)

Pfizer Inc. is set to announce its Q2 financial results, with expected earnings of 46 cents per share and revenue of $13.02 billion. The company received European Commission approval for DURVEQTIX, a gene therapy for hemophilia B. Recent analyst ratings show mixed sentiments, with price targets ranging from $29 to $45.

Benzinga

Merck & Co., Inc.'s (NYSE:MRK) Dismal Stock Performance Reflects Weak Fundamentals

Merck's stock has declined 3.7% over the past three months, with a return on equity (ROE) of 5.7%, significantly below the industry average of 22%. The company's earnings have been shrinking, and its high payout ratio of 110% indicates it is depleting resources to maintain dividend payments. Analysts expect an improvement in ROE to 39% as the payout ratio drops to 32% over the next three years, but caution is advised due to the current unsatisfactory performance.

Yahoo Finance

Is An Earnings Beat In The Cards For Merck Stock?

Merck is set to report Q2 2024 results on July 30, expecting revenue of $15.9 billion and adjusted earnings of $2.20, driven by strong sales of Keytruda and Gardasil. Despite recent stock gains, MRK has underperformed the S&P 500 in 2021 and 2023. The company faces challenges from generic competition but remains optimistic about growth in Keytruda and Gardasil, particularly in China. Valuation estimates suggest MRK is appropriately priced at $135 per share.

Forbes